Works matching IS 20950217 AND DT 2023 AND VI 17 AND IP 6


Results: 14
    1
    2
    3
    4
    5
    6
    7

    BGB-A445, a novel non-ligand-blocking agonistic anti-OX40 antibody, exhibits superior immune activation and antitumor effects in preclinical models.

    Published in:
    Frontiers of Medicine, 2023, v. 17, n. 6, p. 1170, doi. 10.1007/s11684-023-0996-8
    By:
    • Jiang, Beibei;
    • Zhang, Tong;
    • Deng, Minjuan;
    • Jin, Wei;
    • Hong, Yuan;
    • Chen, Xiaotong;
    • Chen, Xin;
    • Wang, Jing;
    • Hou, Hongjia;
    • Gao, Yajuan;
    • Gong, Wenfeng;
    • Wang, Xing;
    • Li, Haiying;
    • Zhou, Xiaosui;
    • Feng, Yingcai;
    • Zhang, Bo;
    • Jiang, Bin;
    • Lu, Xueping;
    • Zhang, Lijie;
    • Li, Yang
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14